-
-
-
-
-
-
-
Biohaven Pharma (BHVN) Tops Q4 EPS by 28c
-
-
-
-
-
-
-
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $54 at RBC Capital
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVN
-
-
-
-
-
-
-
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $66 at RBC Capital
-
-
-
-
-
-
-
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
-
-
-
-
-
-
-
Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments
-
-
-
-
-
-
-
Biohaven Reports First Quarter 2022 Financial Results and Reports Recent Business Developments
-
1,222,760 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

